Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, British Columbia V6T 1Z1, Canada.
Life Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, British Columbia V6T 2A3, Canada.
Bioconjug Chem. 2022 Dec 21;33(12):2381-2397. doi: 10.1021/acs.bioconjchem.2c00465. Epub 2022 Nov 15.
A new, high-denticity, bifunctional ligand─HTPAN-triazole-Bn-NH─has been synthesized and studied in complexation with [Ac]Ac and [In]In for radiopharmaceutical applications. The bifunctional chelator is readily synthesized, using a high-yielding four-step prep, which is highly adaptable and allows for straightforward incorporation of different covalent linkers using Cu-catalyzed alkyne-azide cycloaddition (click) chemistry. Nuclear magnetic resonance (NMR) studies of HTPAN-triazole-Bn-NH with La and In metal ions show the formation of a single, asymmetric complex with each ion in solution, corroborated by density functional theory (DFT) calculations. Radiolabeling studies with [Ac]Ac and [In]In showed highly effective complexation, achieving quantitative radiochemical conversions at low ligand concentrations (<10 M) under mild conditions (RT, 10 min), which is further accompanied by high stability in human serum. The bioconjugate─HTPAN-triazole-Bn-Aoc-Pip-Nle-CycMSH─was prepared for targeting of MC1R-positive tumors, and the corresponding In-radiolabeled tracer was studied . SPECT/CT and biodistribution studies in C57BL/6J mice bearing B16-F10 tumors were performed, with the radiotracer showing good stability; tumor uptake was achieved. This work highlights a new promising and versatile bifunctional chelator, easily prepared and encouraging for Ac/In theranostics.
一种新的、高齿密度、双功能配体─HTPAN-三唑-Bn-NH─已被合成,并研究了其与[Ac]Ac 和 [In]In 的络合,用于放射性药物应用。双功能螯合剂易于合成,采用高产率的四步预合成,具有高度适应性,并允许使用铜催化的炔烃-叠氮化物环加成(点击)化学轻松地掺入不同的共价连接体。HTPAN-三唑-Bn-NH 与 La 和 In 金属离子的核磁共振(NMR)研究表明,在溶液中形成了每个离子的单一、不对称络合物,这得到了密度泛函理论(DFT)计算的证实。用 [Ac]Ac 和 [In]In 进行的放射性标记研究表明,络合非常有效,在温和条件下(RT,10 分钟),在低配体浓度(<10 M)下即可实现定量的放射化学转化率,这进一步伴随着在人血清中的高稳定性。制备了用于靶向 MC1R 阳性肿瘤的生物缀合物─HTPAN-三唑-Bn-Aoc-Pip-Nle-CycMSH─,并研究了相应的 In 放射性示踪剂。在携带 B16-F10 肿瘤的 C57BL/6J 小鼠中进行了 SPECT/CT 和生物分布研究,放射性示踪剂显示出良好的稳定性;实现了肿瘤摄取。这项工作突出了一种新的有前途的、多功能的双功能螯合剂,易于制备,并鼓励用于 Ac/In 治疗。